When Sean Parker was young, he cofounded Napster and changed the way we listen to music. In his twenties, he helped jump-start Facebook and changed the way we interact with each other. Now, at age 38, he’s set on changing something else: the way we treat disease. The Parker Institute for Cancer Immunotherapy, which he founded in 2016, has dedicated $250 million toward using new technologies like Crispr to teach the human body to vanquish cancer. Alex Marson is a scientist building the tools to do just that. His research at UC San Francisco and the Parker Institute rejiggers the DNA of T cells—your immune system’s sentinels—to better recognize and attack malignant mutineers. Parker and Marson sat down to talk about Crispr, genome editing, and the most exciting coding language today: DNA. —Megan Molteni
You Might Also Like...
A Nobel Prize for Jim Allison and Tasuku Honjo: A Win for Cancer Research
Fortune | October 2, 2018
Nobel Prize for Medicine Goes to Cancer Immune Therapy Pioneers
Scientific American | October 1, 2018